Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 32,501 | 15,717 | 7,973 | 86,581 | 2,068 |
| Cost of Goods | 8,191 | 4,984 | 1,094 | 865 | 112 |
| Gross Profit | 24,310 | 10,733 | 6,879 | 85,716 | 1,956 |
| Operating Expenses | 77,693 | 59,331 | 44,150 | 39,384 | 23,816 |
| Operating Income | -53,192 | -47,614 | -37,177 | 47,197 | -21,748 |
| Other Income | 2,041 | 2,731 | 3,237 | 3,025 | 2,620 |
| Pre-tax Income | -51,151 | -44,883 | -33,940 | 50,222 | -19,128 |
| Net Income Continuous | -51,151 | -44,883 | -33,940 | 49,934 | -19,128 |
| Net Income | $-51,151 | $-44,883 | $-33,940 | $49,934 | $-19,128 |
| EPS Basic Total Ops | -0.52 | -0.46 | -0.35 | 0.52 | -0.20 |
| EPS Basic Continuous Ops | -0.52 | -0.46 | -0.35 | 0.52 | -0.20 |
| EPS Diluted Total Ops | -0.52 | -0.46 | -0.35 | 0.52 | -0.20 |
| EPS Diluted Continuous Ops | -0.52 | -0.46 | -0.35 | 0.51 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.52 | -0.46 | -0.35 | 0.52 | -0.20 |
| EBITDA(a) | $-53,893 | $-48,802 | $-38,858 | $45,682 | $-23,553 |